美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
42388-023-26	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20160425	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60 mg/1	30 TABLET in 1 BOTTLE (42388-023-26)
42388-023-36	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20171116	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60 mg/1	30 TABLET in 1 BOTTLE (42388-023-36)
42388-023-37	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20181003	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60 mg/1	15 TABLET in 1 BOTTLE (42388-023-37)
42388-023-46	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60 mg/1	1 BOTTLE in 1 CARTON (42388-023-46) / 30 TABLET in 1 BOTTLE
42388-023-57	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60 mg/1	1 BOTTLE in 1 CARTON (42388-023-57) / 15 TABLET in 1 BOTTLE
42388-024-26	42388-024	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20160425	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	20 mg/1	30 TABLET in 1 BOTTLE (42388-024-26)
42388-024-37	42388-024	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20190227	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	20 mg/1	15 TABLET in 1 BOTTLE (42388-024-37)
42388-024-46	42388-024	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	20 mg/1	1 BOTTLE in 1 CARTON (42388-024-46) / 30 TABLET in 1 BOTTLE
42388-024-57	42388-024	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	20 mg/1	1 BOTTLE in 1 CARTON (42388-024-57) / 15 TABLET in 1 BOTTLE
42388-025-26	42388-025	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20160425	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	40 mg/1	30 TABLET in 1 BOTTLE (42388-025-26)
42388-025-37	42388-025	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20190227	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	40 mg/1	15 TABLET in 1 BOTTLE (42388-025-37)
42388-025-46	42388-025	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	40 mg/1	1 BOTTLE in 1 CARTON (42388-025-46) / 30 TABLET in 1 BOTTLE
42388-025-57	42388-025	HUMAN PRESCRIPTION DRUG	CABOMETYX	cabozantinib	TABLET	ORAL	20230109	N/A	NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	40 mg/1	1 BOTTLE in 1 CARTON (42388-025-57) / 15 TABLET in 1 BOTTLE